Lee, D.; Kim, N.W.; Kim, J.Y.; Lee, J.H.; Noh, J.H.; Lee, H.; Jeong, J.W.; Lee, S.; Kang, J.
Sarcopenia’s Prognostic Impact on Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis. J. Clin. Med. 2021, 10, 5329.
https://doi.org/10.3390/jcm10225329
AMA Style
Lee D, Kim NW, Kim JY, Lee JH, Noh JH, Lee H, Jeong JW, Lee S, Kang J.
Sarcopenia’s Prognostic Impact on Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 2021; 10(22):5329.
https://doi.org/10.3390/jcm10225329
Chicago/Turabian Style
Lee, Donggun, Na Won Kim, Jong Yeob Kim, Joo Hyung Lee, Ji Hyun Noh, Haejun Lee, Jin Woon Jeong, Seungeun Lee, and Jeonghyun Kang.
2021. "Sarcopenia’s Prognostic Impact on Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis" Journal of Clinical Medicine 10, no. 22: 5329.
https://doi.org/10.3390/jcm10225329
APA Style
Lee, D., Kim, N. W., Kim, J. Y., Lee, J. H., Noh, J. H., Lee, H., Jeong, J. W., Lee, S., & Kang, J.
(2021). Sarcopenia’s Prognostic Impact on Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine, 10(22), 5329.
https://doi.org/10.3390/jcm10225329